Classically, the 3 pillars of atrial fibrillation (AF) management have included anticoagulation for prevention of thromboembolism, rhythm control, and rate control. In both prevention and management of AF, a growing body of evidence supports an increased role for comprehensive cardiac risk factor modification (RFM), herein defined as management of traditional modifiable cardiac risk factors, weight loss, and exercise. In this narrative review, we summarize the evidence demonstrating the importance of each facet of RFM in AF prevention and therapy. Additionally, we review emerging data on the importance of weight loss and cardiovascular exercise in prevention and management of AF. (J Am Coll Cardiol 2015;66:2899-906)
A trial fibrillation (AF) is the most common sustained arrhythmia and represents a rapidly growing epidemic (1) . It is projected that the prevalence will rise from 5.2 million in 2010 to 12.1 million in 2030, driven primarily by our aging population (2) . AF is associated with increased morbidity, mortality, and rising health care-associated expenses (3, 4) . Unsurprisingly, many modifiable risk factors associated with atherosclerotic cardiovascular disease (ASCVD) have also been associated with AF (Central Illustration). Although the most recent AF practice guidelines acknowledge these risk factors, they provide no evidence-based recommendations on diet, exercise, and lifestyle changes in AF primary and secondary prevention (5) . In 2013, the Heart Rhythm Society recognized "advancing AF prevention efforts by focusing on risk modification" as a key research focus (6) . Of note, there are numerous other risk factors for AF, such as valvular heart disease, thyroid disease, or chronic obstructive pulmonary disease, which are not thought of as classical risk factors for atherosclerotic heart disease. Such conditions also have known causal relationships with AF and also have implications for management strategies. These other AF risk factors warrant investigation in the work-up of new diagnoses of AF.
OBESITY AND WEIGHT LOSS
The rise in prevalence of obesity has been well documented, particularly in the United States, where an estimated one-third of adults are obese (7) . During the past 5 years, a number of studies have established that obesity is closely linked to AF risk. Body mass index (BMI) is part of prediction models for new-onset AF (8) . The connection between obesity and AF has been shown to occur independently of the many comorbidities associated with obesity (9, 10) .
In the ARIC (Atherosclerosis Risk In Communities) study (N ¼ 14,598), 17% of AF risk was attributed to obesity or overweight status (11 for AF (18) .
In humans, increased BMI has been associated with increased left atrial size (19) , which, in turn, is associated with higher AF risk (20) . Increased pericardial fat volume has also been described in obese individuals and is related to the presence, severity, and post-ablation recurrence of AF, independent of BMI, suggesting a local pathogenic effect of pericardial fat (21 Risk Factor Modification in AF D E C E M B E R 2 9 , 2 0 1 5 : 2 8 9 9 -9 0 6 initiation and perpetuation of AF and may contribute to the association of obesity with AF (27) .
Recent clinical trials demonstrate that weight reduction, in the context of a comprehensive risk factor modification (RFM) plan, has an important role in AF management ( Table 1 .
Risk Factor Modification in AF 
DIABETES
Diabetes is an independent risk factor for AF (57, 58) .
This has been corroborated with long-term prospective population cohort studies. In the Framingham Heart Study, diabetes was associated with 40% higher risk of AF in men and 60% higher risk in women after 38 years of follow-up (59) .
Regarding mechanisms underlying the association of diabetes and AF, cardiac autonomic neuropathy has been implicated by leading to sympathetic overactivity and neural remodeling (60, 61) . Dysfunctional cardiac autonomic activity can trigger AF, especially with changes in vagal tone (62) .
There are limited data on diabetes management and Miller et al.
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